{"id":"https://openalex.org/W2007980073","doi":"https://doi.org/10.1161/atvbaha.107.155739","title":"Hepatic PGC-1\u03b2 Overexpression Induces Combined Hyperlipidemia and Modulates the Response to PPAR\u03b1 Activation","display_name":"Hepatic PGC-1\u03b2 Overexpression Induces Combined Hyperlipidemia and Modulates the Response to PPAR\u03b1 Activation","alternate_titles":[],"publication_year":2007,"publication_date":"2007-10-12","ids":{"openalex":"https://openalex.org/W2007980073","doi":"https://doi.org/10.1161/atvbaha.107.155739","mag":"2007980073","pmid":"https://pubmed.ncbi.nlm.nih.gov/17932310"},"language":"en","primary_location":{"id":"doi:10.1161/atvbaha.107.155739","doi":"https://doi.org/10.1161/atvbaha.107.155739","is_oa":true,"landing_page_url":"https://doi.org/10.1161/atvbaha.107.155739","pdf_url":"https://www.ahajournals.org/doi/pdf/10.1161/ATVBAHA.107.155739","source":{"id":"https://openalex.org/S3485792","display_name":"Arteriosclerosis Thrombosis and Vascular Biology","issn_l":"1079-5642","issn":["1079-5642","1524-4636"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arteriosclerosis, Thrombosis, and Vascular Biology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2007980073"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.ahajournals.org/doi/pdf/10.1161/ATVBAHA.107.155739","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018407491","display_name":"Christopher J. Lelliott","orcid":"https://orcid.org/0000-0001-8087-4530","observed_orcids":["https://orcid.org/0000-0001-8087-4530"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB","SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Christopher J. Lelliott","raw_affiliation_strings":["AstraZeneca R&D, Mo\u0308lndal, Sweden","MRC Clinical Sciences Centre (C.C.S.), Imperial Collage London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca R&D, Mo\u0308lndal, Sweden","institution_ids":["https://openalex.org/I4210143795"]},{"raw_affiliation_string":"MRC Clinical Sciences Centre (C.C.S.), Imperial Collage London, London, UK","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005981924","display_name":"Anna Ljungberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]},{"id":"https://openalex.org/I881427289","display_name":"University of Gothenburg","ror":"https://ror.org/01tm6cn81","country_code":"SE","type":"education","lineage":["https://openalex.org/I881427289"]}],"countries":["GB","SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anna Ljungberg","raw_affiliation_strings":["AstraZeneca R&D, Mo\u0308lndal, Sweden","Wallenberg Laboratory for Cardiovascular Research and the Department of Physiology/Endocrinology, The Sahlgrenska Academy at Go\u0308teborg University, Go\u0308teborg, Sweden","MRC Clinical Sciences Centre (C.C.S.), Imperial Collage London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca R&D, Mo\u0308lndal, Sweden","institution_ids":["https://openalex.org/I4210143795"]},{"raw_affiliation_string":"Wallenberg Laboratory for Cardiovascular Research and the Department of Physiology/Endocrinology, The Sahlgrenska Academy at Go\u0308teborg University, Go\u0308teborg, Sweden","institution_ids":["https://openalex.org/I881427289"]},{"raw_affiliation_string":"MRC Clinical Sciences Centre (C.C.S.), Imperial Collage London, London, UK","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016064806","display_name":"Andrea Ahnmark","orcid":"https://orcid.org/0000-0001-8932-4631","observed_orcids":["https://orcid.org/0000-0001-8932-4631"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB","SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Andrea Ahnmark","raw_affiliation_strings":["AstraZeneca R&D, Mo\u0308lndal, Sweden","MRC Clinical Sciences Centre (C.C.S.), Imperial Collage London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca R&D, Mo\u0308lndal, Sweden","institution_ids":["https://openalex.org/I4210143795"]},{"raw_affiliation_string":"MRC Clinical Sciences Centre (C.C.S.), Imperial Collage London, London, UK","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034924538","display_name":"Lena William\u2010Olsson","orcid":"https://orcid.org/0000-0002-2604-2183","observed_orcids":["https://orcid.org/0000-0002-2604-2183"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB","SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lena William-Olsson","raw_affiliation_strings":["AstraZeneca R&D, Mo\u0308lndal, Sweden","MRC Clinical Sciences Centre (C.C.S.), Imperial Collage London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca R&D, Mo\u0308lndal, Sweden","institution_ids":["https://openalex.org/I4210143795"]},{"raw_affiliation_string":"MRC Clinical Sciences Centre (C.C.S.), Imperial Collage London, London, UK","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001132418","display_name":"Kim Ekroos","orcid":"https://orcid.org/0000-0001-6810-4736","observed_orcids":["https://orcid.org/0000-0001-6810-4736"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]},{"id":"https://openalex.org/I87653560","display_name":"VTT Technical Research Centre of Finland","ror":"https://ror.org/04b181w54","country_code":"FI","type":"nonprofit","lineage":["https://openalex.org/I4210089493","https://openalex.org/I87653560"]},{"id":"https://openalex.org/I881427289","display_name":"University of Gothenburg","ror":"https://ror.org/01tm6cn81","country_code":"SE","type":"education","lineage":["https://openalex.org/I881427289"]}],"countries":["FI","GB","SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kim Ekroos","raw_affiliation_strings":["AstraZeneca R&D, Mo\u0308lndal, Sweden","Wallenberg Laboratory for Cardiovascular Research and the Department of Physiology/Endocrinology, The Sahlgrenska Academy at Go\u0308teborg University, Go\u0308teborg, Sweden","VTT Technical Research Centre of Finland, Espoo, Finland","MRC Clinical Sciences Centre (C.C.S.), Imperial Collage London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca R&D, Mo\u0308lndal, Sweden","institution_ids":["https://openalex.org/I4210143795"]},{"raw_affiliation_string":"Wallenberg Laboratory for Cardiovascular Research and the Department of Physiology/Endocrinology, The Sahlgrenska Academy at Go\u0308teborg University, Go\u0308teborg, Sweden","institution_ids":["https://openalex.org/I881427289"]},{"raw_affiliation_string":"VTT Technical Research Centre of Finland, Espoo, Finland","institution_ids":["https://openalex.org/I87653560"]},{"raw_affiliation_string":"MRC Clinical Sciences Centre (C.C.S.), Imperial Collage London, London, UK","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082864510","display_name":"Anders Elmgren","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB","SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anders Elmgren","raw_affiliation_strings":["AstraZeneca R&D, Mo\u0308lndal, Sweden","MRC Clinical Sciences Centre (C.C.S.), Imperial Collage London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca R&D, Mo\u0308lndal, Sweden","institution_ids":["https://openalex.org/I4210143795"]},{"raw_affiliation_string":"MRC Clinical Sciences Centre (C.C.S.), Imperial Collage London, London, UK","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043397234","display_name":"Gunnel Arnerup","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB","SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gunnel Arnerup","raw_affiliation_strings":["Safety Assessment Sweden, AstraZeneca R&D, So\u0308derta\u0308lje, Sweden","MRC Clinical Sciences Centre (C.C.S.), Imperial Collage London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Safety Assessment Sweden, AstraZeneca R&D, So\u0308derta\u0308lje, Sweden","institution_ids":["https://openalex.org/I4210143795"]},{"raw_affiliation_string":"MRC Clinical Sciences Centre (C.C.S.), Imperial Collage London, London, UK","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005712216","display_name":"Carol C. Shoulders","orcid":"https://orcid.org/0000-0003-2218-1095","observed_orcids":["https://orcid.org/0000-0003-2218-1095"]},"institutions":[{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Carol C. Shoulders","raw_affiliation_strings":["MRC Clinical Sciences Centre, Imperial","MRC Clinical Sciences Centre (C.C.S.), Imperial Collage London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Clinical Sciences Centre, Imperial","institution_ids":[]},{"raw_affiliation_string":"MRC Clinical Sciences Centre (C.C.S.), Imperial Collage London, London, UK","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086636722","display_name":"Jan Oscarsson","orcid":"https://orcid.org/0000-0002-4573-517X","observed_orcids":["https://orcid.org/0000-0002-4573-517X"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]},{"id":"https://openalex.org/I881427289","display_name":"University of Gothenburg","ror":"https://ror.org/01tm6cn81","country_code":"SE","type":"education","lineage":["https://openalex.org/I881427289"]}],"countries":["GB","SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jan Oscarsson","raw_affiliation_strings":["AstraZeneca R&D, Mo\u0308lndal, Sweden","Wallenberg Laboratory for Cardiovascular Research and the Department of Physiology/Endocrinology, The Sahlgrenska Academy at Go\u0308teborg University, Go\u0308teborg, Sweden","MRC Clinical Sciences Centre (C.C.S.), Imperial Collage London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca R&D, Mo\u0308lndal, Sweden","institution_ids":["https://openalex.org/I4210143795"]},{"raw_affiliation_string":"Wallenberg Laboratory for Cardiovascular Research and the Department of Physiology/Endocrinology, The Sahlgrenska Academy at Go\u0308teborg University, Go\u0308teborg, Sweden","institution_ids":["https://openalex.org/I881427289"]},{"raw_affiliation_string":"MRC Clinical Sciences Centre (C.C.S.), Imperial Collage London, London, UK","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040428765","display_name":"Daniel Lind\u00e9n","orcid":"https://orcid.org/0000-0003-4158-8018","observed_orcids":["https://orcid.org/0000-0003-4158-8018"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]},{"id":"https://openalex.org/I881427289","display_name":"University of Gothenburg","ror":"https://ror.org/01tm6cn81","country_code":"SE","type":"education","lineage":["https://openalex.org/I881427289"]}],"countries":["GB","SE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Daniel Linde\u0301n","raw_affiliation_strings":["AstraZeneca R&D, Mo\u0308lndal, Sweden","Wallenberg Laboratory for Cardiovascular Research and the Department of Physiology/Endocrinology, The Sahlgrenska Academy at Go\u0308teborg University, Go\u0308teborg, Sweden","MRC Clinical Sciences Centre (C.C.S.), Imperial Collage London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca R&D, Mo\u0308lndal, Sweden","institution_ids":["https://openalex.org/I4210143795"]},{"raw_affiliation_string":"Wallenberg Laboratory for Cardiovascular Research and the Department of Physiology/Endocrinology, The Sahlgrenska Academy at Go\u0308teborg University, Go\u0308teborg, Sweden","institution_ids":["https://openalex.org/I881427289"]},{"raw_affiliation_string":"MRC Clinical Sciences Centre (C.C.S.), Imperial Collage London, London, UK","institution_ids":["https://openalex.org/I47508984"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5040428765"],"corresponding_institution_ids":["https://openalex.org/I4210143795","https://openalex.org/I47508984","https://openalex.org/I881427289"],"apc_list":null,"apc_paid":null,"fwci":2.0254,"has_fulltext":true,"cited_by_count":47,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.86081736,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"27","issue":"12","first_page":"2707","last_page":"2713"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.9721999764442444,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.9721999764442444,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.012500000186264515,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.004000000189989805,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pgc-1beta","display_name":"PGC-1\u03b2","score":0.953000009059906},{"id":"https://openalex.org/keywords/pgc-1alpha","display_name":"PGC-1\u03b1","score":0.9900000095367432},{"id":"https://openalex.org/keywords/hyperlipidemia","display_name":"hyperlipidemia","score":0.8230000138282776},{"id":"https://openalex.org/keywords/pparalpha-agonists","display_name":"PPAR\u03b1 agonist","score":0.7799999713897705},{"id":"https://openalex.org/keywords/wy-14643","display_name":"Wy-14,643","score":0.9580000042915344},{"id":"https://openalex.org/keywords/high-fat-diet","display_name":"high-fat diet","score":0.9070000052452087},{"id":"https://openalex.org/keywords/hepatic-lipid-metabolism","display_name":"hepatic lipid metabolism","score":0.7260000109672546},{"id":"https://openalex.org/keywords/apolipoprotein-b","display_name":"apolipoprotein B","score":0.8399999737739563},{"id":"https://openalex.org/keywords/hepatic-triglyceride-secretion","display_name":"hepatic triglyceride secretion","score":0.8669999837875366},{"id":"https://openalex.org/keywords/fatty-acid-uptake","display_name":"fatty acid uptake","score":0.6150000095367432},{"id":"https://openalex.org/keywords/hepatic-lipase","display_name":"hepatic lipase","score":0.7580000162124634},{"id":"https://openalex.org/keywords/srebp-1c","display_name":"SREBP-1c","score":0.9710000157356262},{"id":"https://openalex.org/keywords/fatty-acid-oxidation","display_name":"fatty acid oxidation","score":0.9039999842643738},{"id":"https://openalex.org/keywords/fas","display_name":"Fas","score":0.5260000228881836},{"id":"https://openalex.org/keywords/adenoviral-gene-transfer","display_name":"adenoviral gene transfer","score":0.5730000138282776}],"concepts":[{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.8070663809776306},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.8064773678779602},{"id":"https://openalex.org/C2779091943","wikidata":"https://www.wikidata.org/wiki/Q1079120","display_name":"Hyperlipidemia","level":3,"score":0.719901978969574},{"id":"https://openalex.org/C2779828298","wikidata":"https://www.wikidata.org/wiki/Q4035577","display_name":"CD36","level":3,"score":0.6726536750793457},{"id":"https://openalex.org/C77445288","wikidata":"https://www.wikidata.org/wiki/Q637488","display_name":"Coactivator","level":4,"score":0.650349497795105},{"id":"https://openalex.org/C187345961","wikidata":"https://www.wikidata.org/wiki/Q419629","display_name":"Peroxisome proliferator-activated receptor","level":3,"score":0.6265288591384888},{"id":"https://openalex.org/C2778913445","wikidata":"https://www.wikidata.org/wiki/Q186319","display_name":"Triglyceride","level":3,"score":0.4865318834781647},{"id":"https://openalex.org/C85051948","wikidata":"https://www.wikidata.org/wiki/Q416064","display_name":"Sterol regulatory element-binding protein","level":4,"score":0.47422170639038086},{"id":"https://openalex.org/C62746215","wikidata":"https://www.wikidata.org/wiki/Q14890615","display_name":"Apolipoprotein B","level":3,"score":0.4639197587966919},{"id":"https://openalex.org/C2780213950","wikidata":"https://www.wikidata.org/wiki/Q908765","display_name":"Hepatic lipase","level":4,"score":0.44263768196105957},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4372738301753998},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.428003191947937},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.42029261589050293},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.25566351413726807},{"id":"https://openalex.org/C86339819","wikidata":"https://www.wikidata.org/wiki/Q407384","display_name":"Transcription factor","level":3,"score":0.2355118691921234},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1601274311542511},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.13851243257522583},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.12747293710708618},{"id":"https://openalex.org/C2778718757","wikidata":"https://www.wikidata.org/wiki/Q143623","display_name":"Sterol","level":3,"score":0.05276641249656677},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000071248","descriptor_name":"Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000103","descriptor_name":"Acetyl-CoA Carboxylase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000256","descriptor_name":"Adenoviridae","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001055","descriptor_name":"Apolipoproteins B","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004041","descriptor_name":"Dietary Fats","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005227","descriptor_name":"Fatty Acids","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005786","descriptor_name":"Gene Expression Regulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D005822","descriptor_name":"Genetic Vectors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006950","descriptor_name":"Hyperlipidemia, Familial Combined","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D006950","descriptor_name":"Hyperlipidemia, Familial Combined","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006950","descriptor_name":"Hyperlipidemia, Familial Combined","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D008049","descriptor_name":"Lipase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D012333","descriptor_name":"RNA, Messenger","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014157","descriptor_name":"Transcription Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014161","descriptor_name":"Transduction, Genetic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014280","descriptor_name":"Triglycerides","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015534","descriptor_name":"Trans-Activators","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015534","descriptor_name":"Trans-Activators","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D015854","descriptor_name":"Up-Regulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018110","descriptor_name":"Receptors, Lipoprotein","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018955","descriptor_name":"CD36 Antigens","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D047493","descriptor_name":"PPAR alpha","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D047493","descriptor_name":"PPAR alpha","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D050356","descriptor_name":"Lipid Metabolism","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D050356","descriptor_name":"Lipid Metabolism","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D051048","descriptor_name":"Diacylglycerol O-Acyltransferase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051780","descriptor_name":"Sterol Regulatory Element Binding Protein 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D064429","descriptor_name":"Fatty Acid Synthases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1161/atvbaha.107.155739","doi":"https://doi.org/10.1161/atvbaha.107.155739","is_oa":true,"landing_page_url":"https://doi.org/10.1161/atvbaha.107.155739","pdf_url":"https://www.ahajournals.org/doi/pdf/10.1161/ATVBAHA.107.155739","source":{"id":"https://openalex.org/S3485792","display_name":"Arteriosclerosis Thrombosis and Vascular Biology","issn_l":"1079-5642","issn":["1079-5642","1524-4636"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arteriosclerosis, Thrombosis, and Vascular Biology","raw_type":"journal-article"},{"id":"pmid:17932310","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17932310","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arteriosclerosis, thrombosis, and vascular biology","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.998.941","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.998.941","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://atvb.ahajournals.org/content/atvbaha/27/12/2707.full.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1161/atvbaha.107.155739","doi":"https://doi.org/10.1161/atvbaha.107.155739","is_oa":true,"landing_page_url":"https://doi.org/10.1161/atvbaha.107.155739","pdf_url":"https://www.ahajournals.org/doi/pdf/10.1161/ATVBAHA.107.155739","source":{"id":"https://openalex.org/S3485792","display_name":"Arteriosclerosis Thrombosis and Vascular Biology","issn_l":"1079-5642","issn":["1079-5642","1524-4636"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arteriosclerosis, Thrombosis, and Vascular Biology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2007980073.pdf","grobid_xml":"https://content.openalex.org/works/W2007980073.grobid-xml"},"referenced_works_count":44,"referenced_works":["https://openalex.org/W1523158326","https://openalex.org/W1603786143","https://openalex.org/W1960389768","https://openalex.org/W1964031474","https://openalex.org/W1964876127","https://openalex.org/W1971082641","https://openalex.org/W1974115865","https://openalex.org/W1976559252","https://openalex.org/W1976998737","https://openalex.org/W1977779461","https://openalex.org/W1982359478","https://openalex.org/W1990755760","https://openalex.org/W1996446469","https://openalex.org/W1996821192","https://openalex.org/W2006339456","https://openalex.org/W2008632158","https://openalex.org/W2017109633","https://openalex.org/W2022543078","https://openalex.org/W2026833147","https://openalex.org/W2031633187","https://openalex.org/W2035554684","https://openalex.org/W2038654926","https://openalex.org/W2044782567","https://openalex.org/W2051999166","https://openalex.org/W2087431894","https://openalex.org/W2088845412","https://openalex.org/W2091673304","https://openalex.org/W2092823680","https://openalex.org/W2096330168","https://openalex.org/W2102785858","https://openalex.org/W2113961541","https://openalex.org/W2124615340","https://openalex.org/W2134120897","https://openalex.org/W2144829836","https://openalex.org/W2145828144","https://openalex.org/W2157619650","https://openalex.org/W2157854383","https://openalex.org/W2158138282","https://openalex.org/W2160518844","https://openalex.org/W2160769801","https://openalex.org/W2167591543","https://openalex.org/W2198678228","https://openalex.org/W2615637571","https://openalex.org/W4249225294"],"related_works":["https://openalex.org/W2102785858","https://openalex.org/W2008777641","https://openalex.org/W4236099783","https://openalex.org/W7097564634","https://openalex.org/W1981436281","https://openalex.org/W2035233196","https://openalex.org/W2036407890","https://openalex.org/W2028200390","https://openalex.org/W1735315486"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Previous":[1],"studies":[2],"have":[3],"indicated":[4],"that":[5,30],"the":[6,22,45,55,60,189],"hyperlipidemia":[7,91,180],"and":[8,29,35,75,102,109,126,142,167,170],"gene":[9,151,197],"expression":[10,104,122],"changes":[11,120],"induced":[12],"by":[13],"a":[14,206],"short-term":[15],"high-fat":[16],"diet":[17],"(HFD)":[18],"are":[19],"mediated":[20],"through":[21],"peroxisome":[23],"proliferator-activated":[24],"receptor":[25],"gamma":[26],"coactivator":[27],"(PGC)-1beta,":[28],"in":[31,46,53,121,138],"vitro":[32],"both":[33],"PGC-1beta":[34,86,116,130,141,159,176,186,203],"PGC":[36],"-1alpha":[37],"increase":[38],"PPARalpha-mediated":[39],"transcriptional":[40],"activities.":[41],"Here,":[42],"we":[43],"examined":[44],"vivo":[47],"effects":[48,192],"of":[49,59,124,182,193,201],"these":[50],"two":[51],"coactivators":[52],"potentiating":[54],"lipid":[56],"lowering":[57],"properties":[58],"PPARalpha":[61,108,125,194],"agonist":[62],"Wy14,643":[63],"(Wy).":[64],"METHODS":[65],"AND":[66],"RESULTS:":[67],"C57BL/6":[68],"mice":[69],"were":[70,105,114],"fed":[71],"chow":[72],"or":[73,81],"HFD":[74],"transduced":[76],"with":[77],"adenoviruses":[78],"encoding":[79],"PGC-1alpha":[80,143],"PGC-1beta.":[82],"On":[83,157],"chow,":[84],"hepatic":[85,110,154,162,202],"overexpression":[87,117,144,160,177,187],"caused":[88,178],"severe":[89],"combined":[90,179,210],"including":[92],"elevated":[93],"plasma":[94,171],"apolipoprotein":[95],"B":[96],"levels.":[97,173],"Hepatic":[98,175,185],"triglyceride":[99,155,172],"secretion,":[100],"DGAT1,":[101],"FAT/CD36":[103],"increased":[106,165],"whereas":[107],"lipase":[111],"mRNA":[112,169],"levels":[113,123],"reduced.":[115],"blunted":[118],"Wy-mediated":[119],"downstream":[127],"genes.":[128],"Furthermore,":[129],"did":[131,145],"not":[132,146],"potentiate":[133],"Wy-stimulated":[134],"fatty":[135],"acid":[136],"oxidation":[137],"primary":[139],"hepatocytes.":[140],"alter":[147],"SREBP-1c,":[148,163],"SREBP-1c":[149,183],"target":[150],"expression,":[152],"nor":[153],"content.":[156],"HFD,":[158],"decreased":[161],"yet":[164],"FAS":[166],"ACCalpha":[168],"CONCLUSIONS:":[174],"independent":[181],"activation.":[184],"reduced":[188],"potentially":[190],"beneficial":[191],"activation":[195],"on":[196],"expression.":[198],"Thus,":[199],"inhibition":[200],"may":[204],"provide":[205],"therapy":[207],"for":[208],"treating":[209],"hyperlipidemia.":[211]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2007980073","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
